Answers are grounded in this paper and cite their sources.
Genome-wide CRISPR screening reveals mTOR inhibition enhances ferroptosis in head and neck cancer, suggesting potential for combination therapy.
Combination therapy with mTORi and auranofin enhances ferroptosis. (Related to Figure 6)
No takes yet. Share an insight, caveat, or question.
Koshizuka et al. (2025) studied this question.
Synapse has enriched 8 closely related papers on similar clinical questions. Consider them for comparative context: